Arcutis Biotherapeutics
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Public
- Established
- 2016-01-06
- Employees
- 296
- Market Cap
- $1.2B
- Website
- http://www.arcutis.com
- Introduction
Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.
The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-08-20
- Last Posted Date
- 2022-09-02
- Lead Sponsor
- Arcutis Biotherapeutics, Inc.
- Target Recruit Count
- 331
- Registration Number
- NCT03638258
- Locations
- ๐บ๐ธ
Arcutis Clinical Site 12, Miami, Florida, United States
๐จ๐ฆArcutis Clinical Site 26, Markham, Ontario, Canada
๐บ๐ธArcutis Clinical Site 21, Louisville, Kentucky, United States
Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-01-05
- Last Posted Date
- 2022-08-04
- Lead Sponsor
- Arcutis Biotherapeutics, Inc.
- Target Recruit Count
- 91
- Registration Number
- NCT03392168
- Locations
- ๐บ๐ธ
Mosaic Dermatology, Santa Monica, California, United States
๐จ๐ฆResearch by ICLS, Oakville, Ontario, Canada
๐จ๐ฆSKiN Centre for Dermatology, Peterborough, Ontario, Canada
ยฉ Copyright 2024. All Rights Reserved by MedPath